Results 101 to 110 of about 9,080 (215)

Antifungal Susceptibility Profile of Aspergillus Strains Isolated From the Lower Respiratory Tract in Eastern Indian Patients: A Hospital‐Based Study

open access: yesMicrobiologyOpen, Volume 14, Issue 6, December 2025.
Treatment for chronic to invasive pulmonary aspergillosis typically involves azole antifungal drugs, although studies have shown varying minimum inhibitory concentrations (MIC) for these medications, with a growing concern over voriconazole resistance.
Aishwarya Nikhil   +8 more
wiley   +1 more source

Pulmonary Mucormycosis (Zygomycosis) Presenting as an Infective Exacerbation of Chronic Obstructive Pulmonary Disease

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2018
Mucormycosis is a life-threatening fungal infection whose incidence has been rising recently, mainly due to the increasing use of immunosuppressive and corticosteroid treatment.
Elena Koushiappi   +4 more
doaj   +1 more source

Intracerebral Aspergillus abscess: Case report and review of the literature [PDF]

open access: yes, 1997
Intracranial aspergillosis is a rare pathologic condition, difficult to treat and often fatal, which generally affects immunodepressed patients. A case of brain abscess secondary to pulmonary localization in a patient with a non-Hodgkin lymphoma is ...
Artico, M   +4 more
core   +1 more source

Drug-induced hypersensitivity syndrome by liposomal amphotericin-B: a case report [PDF]

open access: yes, 2015
BACKGROUND: Liposomal amphotericin-B (Ambisome(®)) is widely used antifungal drug for treatments of invasive fungal infections. The use of liposomal amphotericin-B is increasing in medical setting because of its tolerability and potent antifungal ...
Hideo Kato   +7 more
core   +1 more source

Mucormycosis causing pulmonary artery aneurysm

open access: yesRespiratory Medicine Case Reports, 2015
Pulmonary artery aneurysm (PAA) is an uncommon entity and is usually congenital in origin or secondary to pulmonary arterial hypertension. Infections causing PAA are few, tuberculosis and bacterial infections being the common causative organisms. There have been few cases reported previously, in which the organism causing PAA was found to be a rare ...
Lakshman Ramachandran   +3 more
openaire   +3 more sources

Lung Abscess Gone Rogue: Unmasking the Mucor Menace

open access: yesJournal of Association of Pulmonologist of Tamil Nadu
Pulmonary mucormycosis is a rare but aggressive fungal infection that often mimics other pulmonary pathologies, such as tuberculosis, leading to diagnostic delays.
GD Anur Ramakrishnan, Ilakiya Palanivel
doaj   +1 more source

Splenic infarction: an update on William Osler\u27s observations. [PDF]

open access: yes, 2010
BACKGROUND: Osler taught that splenic infarction presents with left upper abdominal quadrant pain, tenderness and swelling accompanied by a peritoneal friction rub.
Aharoni, MD, Dvora   +5 more
core   +1 more source

An Antimicrobial Peptidomimetic Induces Mucorales Cell Death through Mitochondria-Mediated Apoptosis [PDF]

open access: yes, 2013
The incidence of mucormycosis has dramatically increased in immunocompromised patients. Moreover, the array of cellular targets whose inhibition results in fungal cell death is rather limited.
Albert, Nathaniel   +7 more
core   +2 more sources

A case report on successfully treated invasive pulmonary mucormycosis in a patient with poorly controlled diabetes mellitus

open access: yesAsian Journal of Internal Medicine
Although fungal infections are common in clinical practice, usually they are superficial and invasive infections are very rare among immunocompetent people.
P. Dikshaladevi   +3 more
doaj   +1 more source

Soluble suppression of tumorigenicity 2 and echocardiography in sepsis [PDF]

open access: yes, 2016
Soluble suppression of tumorigenicity 2 (sST2) has emerged as a biomarker of cardiac stretch or remodeling, and has demonstrated a role in acutely decompensated heart failure. However, its role in sepsis-induced cardiac dysfunction is still unknown.
Hanah Kim   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy